HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Clarins Total Double Serum Reformulated With 42 “Active” Ingredients

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Clarins is introducing Total Double Serum in August as an updated version of its anti-aging skin care product Double Serum, which launched in 1985. Positioned as a "cure" for aging skin, Total Double Serum boasts 42 "active" ingredients in its formula

You may also be interested in...



Clarins Super Restorative Serum Debuts With Brand’s Highest Price Point

Clarins Super Restorative Serum is bowing this fall priced at $110, representing a significant premium to the brand's existing skin care products

Clarins Super Restorative Serum Debuts With Brand’s Highest Price Point

Clarins Super Restorative Serum is bowing this fall priced at $110, representing a significant premium to the brand's existing skin care products

Clarins Multi-Active Day Cream Reformulated With New Plant Extract

Clarins Multi-Active Day Cream Protection Plus, bowing in mid-January, incorporates plant extract mourera fluviatilis to offer enhanced skin protection and line prevention.

Table

View full table

Tags:
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS010426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By